Guadalquiver, Agripina L.

HRN: 27-44-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/16/2025
07/23/2025
IV
4.5
Q8
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: